StockData
TELA Bio, Inc. logo

TELA Bio, Inc. (TELA) stock

TELANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$0.78+0.02 (+2.36%)

Close on Nov 18, 2026Market cap $35.02MP/E –Yield –

TELA Bio price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

TELA Bio's price to sales ratio was 0.5× on Nov 11, 2026, against 0.6× a year earlier. Over the last 5 years it ranged from 0.3× to 6.9×, with a median of 1.9×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.5×−0.1
2025Dec 31, 20250.6×−0.5
2024Dec 31, 20241.1×−2.0
2023Dec 29, 20233.1×−2.7
2022Dec 30, 20225.8×−1.2
2021Dec 31, 20216.9×−7.1
2020Dec 31, 202014.1×+13.7
2019Dec 31, 20190.3×–

More TELA Bio figures

See a number that looks wrong?